Higher Rates of Decline for Women and Apolipoprotein E ε4 Carriers

Por Holland, D., Desikan, R.S., Dale, A.M., McEvoy, L.K.
Publicado em 2013

Predicting MCI outcome with clinically available MRI and CSF biomarkers

Por Heister, D., Brewer, J.B., Magda, S., Blennow, K., McEvoy, L.K.
Publicado em 2011

Electroencephalographic imaging of higher brain function.

Por Gevins, A, Smith, M E, McEvoy, L K, Leong, H, Le, J
Publicado em 1999

Sex and Age Differences in the Association of Blood Pressure and Hypertension with Cognitive Function in the Elderly: The Rancho Bernardo Study

Por Kritz-Silverstein, D., Laughlin, G.A., McEvoy, L.K., Barrett-Connor, E.
Publicado no J Prev Alzheimers Dis (2017)

Moderate, Regular Alcohol Consumption is Associated with Higher Cognitive Function in Older Community-Dwelling Adults

Por Reas, E.T., Laughlin, G.A., Kritz-Silverstein, D., Barrett-Connor, E., McEvoy, L.K.
Publicado no J Prev Alzheimers Dis (2016)

Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls

Por Murphy, E.A., Holland, D., Donohue, M., McEvoy, L.K., Hagler, D.J., Dale, A.M., Brewer, J. B.
Publicado em 2010

Multi-modal imaging predicts memory performance in normal aging and cognitive decline

Por Walhovd, K. B., Fjell, A. M., Dale, A. M., McEvoy, L. K., Brewer, J., Karow, D. S., Salmon, D. P., Fennema-Notestine, C.
Publicado em 2008

Global clinical dementia rating of 0.5 in MCI masks variability related to level of function

Por Chang, Y.-L., Bondi, M.W., McEvoy, L.K., Fennema-Notestine, C., Salmon, D.P., Galasko, D., Hagler, D.J., Dale, A.M.
Publicado em 2011

Regional rates of neocortical atrophy from normal aging to early Alzheimer disease

Por McDonald, C R., McEvoy, L K., Gharapetian, L, Fennema-Notestine, C, Hagler, D J., Holland, D, Koyama, A, Brewer, J B., Dale, A M.
Publicado em 2009

Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease

Por Walhovd, K.B., Fjell, A.M., Brewer, J., McEvoy, L.K., Fennema-Notestine, C., Hagler, D.J., Jennings, R.G., Karow, D., Dale, A.M.
Publicado em 2010

Apolipoprotein E ε4 Does Not Modulate Amyloid-β–Associated Neurodegeneration in Preclinical Alzheimer Disease

Por Desikan, R.S., McEvoy, L.K., Holland, D., Thompson, W.K., Brewer, J.B., Aisen, P.S., Andreassen, O.A., Hyman, B.T., Sperling, R.A., Dale, A.M.
Publicado em 2013

Neuroimaging Enrichment Strategy for Secondary Prevention Trials in Alzheimer’s Disease

Por McEvoy, L.K., Edland, S.D., Holland, D., Hagler, D.J., Roddey, J.C., Fennema-Notestine, C., Salmon, D.P., Koyama, A.K., Aisen, P.S., Brewer, J.B., Dale, A.M.
Publicado em 2010

Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci

Por Andreassen, O A, Harbo, H F, Wang, Y, Thompson, W K, Schork, A J, Mattingsdal, M, Zuber, V, Bettella, F, Ripke, S, Kelsoe, J R, Kendler, K S, O'Donovan, M C, Sklar, P, McEvoy, L K, Desikan, R S, Lie, B A, Djurovic, S, Dale, A M
Publicado no Mol Psychiatry (2015)